Common antibiotic could block deadly infection in vulnerable liver patients

NCT ID NCT04153604

Summary

This study looked at whether the antibiotic doxycycline can safely prevent a serious abdominal infection called spontaneous bacterial peritonitis (SBP) in people with advanced liver disease. Researchers compared doxycycline to standard preventive medications in over 800 patients to see which was better at stopping the infection from coming back. The goal was to find a safe and effective alternative for long-term prevention, as current standard drugs can have significant side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Methodist Dallas Medical Center

    Dallas, Texas, 75203, United States

Conditions

Explore the condition pages connected to this study.